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slet cell autoantigen 512 (ICA512)/IA-2 is a receptor
tyrosine phosphatase-like protein associated with the
insulin secretory granules (SGs) of pancreatic 
 
 
 
-cells.
Here, we show that exocytosis of SGs and insertion of
ICA512 in the plasma membrane promotes the Ca
 
2
 
 
 
-
dependent cleavage of ICA512 cytoplasmic domain by
 
 
 
-calpain. This cleavage occurs at the plasma membrane
and generates an ICA512 cytosolic fragment that is
I
 
targeted to the nucleus, where it binds the E3-SUMO
ligase protein inhibitor of activated signal transducer and
activator of transcription-y (PIASy) and up-regulates insulin
expression. Accordingly, this novel pathway directly links
regulated exocytosis of SGs and control of gene expression
in 
 
 
 
-cells, whose impaired insulin production and secretion
causes diabetes.
 
Introduction
 
Neuroendocrine cells, including endocrine cells of the pancreatic
islets, modulate physiological activities through the regulated
secretion of peptide hormones and neuropeptides, such as insulin.
These signaling molecules are stored intracellularly within
secretory granules (SGs) that fuse with the plasma membrane in
response to various stimuli and release extracellularly their con-
tent. Insulin-containing SGs of pancreatic 
 
 
 
-cells, in particular,
undergo exocytosis when blood glucose levels are 
 
 
 
5.5 mM.
As insulin lowers blood glucose levels, deficits of its produc-
tion, secretion, or signaling cause hyperglycemia and diabetes,
the most common metabolic disorder in humans. Still unclear is
how pancreatic 
 
 
 
-cells, and neuroendocrine cells in general,
constantly monitor their own secretory activity and adjust their
hormone and gene expression profile accordingly.
Islet cell autoantigen 512 (ICA512; also known as IA-2)
is an intrinsic membrane protein of insulin SGs and neuro-
secretory granules in general (Solimena et al., 1996). This type
I transmembrane protein, which is a major autoimmune target
in type 1 diabetes (Lan et al., 1994; Rabin et al., 1994), belongs
to the receptor protein tyrosine phosphatase (PTP) family due
to the inclusion of a single PTP cytosolic domain lacking
phosphatase activity (Magistrelli et al., 1996). Deletion of
ICA512 in mice impairs insulin secretion (Saeki et al., 2002)
for reasons that are unclear. In view of its relationship with
receptor tyrosine phosphatases and SGs, we investigated here
whether or not ICA512 links regulated secretion and signal
transduction in 
 
 
 
-cells. Our findings indicate that the exocytosis
of insulin SGs triggers the cleavage of ICA512 cytoplasmic
domain, which, in turn, translocates to the nucleus and promotes
insulin gene expression.
 
Results
 
Cleavage of ICA512 upon stimulation of 
insulin secretion
 
Pro-ICA512 is a glycoprotein of 110 kD. Processing of its
ectodomain by a furin-like protease during SG maturation
converts pro-ICA512 into the mature ICA512-transmembrane
fragment (ICA512-TMF) of 65 kD, which is found on SGs
(Solimena et al., 1996). Stimulation of rat insulinoma cells-1
(INS-1) with high glucose (25 mM) and high K
 
 
 
 (55 mM)
induces pro-ICA512 biosynthesis and reduces ICA512-TMF
levels (Ort et al., 2001; Fig. 1 A, lanes 1 and 2). This dual effect
 
The online version of this article includes supplemental material.
Correspondence to Michele Solimena: michele.solimena@mailbox.tu-dresden.de
Abbreviations used in this paper: APP, amyloid precursor protein; CPE, carboxy-
peptidase E; FRET, fluorescence resonance energy transfer; ICA512, Islet Cell
Autoantigen 512; ICA512-CCF, ICA512-cleaved cytosolic fragment; ICA512-
TMF, ICA512-transmembrane fragment; INS-1, insulinoma cells-1; PIAS,
protein inhibitor of activated STAT; PTP, protein tyrosine phosphatase; SG,
secretory granule; siRNA, short-interfering RNA; STAT, signal transducer and
activator of transcription. 
JCB • VOLUME 167 • NUMBER 6 • 2004 1064
Figure 1. ICA512 cytoplasmic domain is cleaved by  -calpain in response to stimulation of  -cells. (A) Western blot for ICA512 (top) and  -tubulin (bottom) on
40  g of protein from INS-1 cells that had been incubated with resting or stimulating buffer for 105 min following 1 h at rest. Protease inhibitors L-685,458 and
calpeptin were added at indicated concentrations. (B) Western blots for ICA512 (top) and  -tubulin (bottom) on 30  g of protein from rat islets that were
incubated with 0 (resting) or 25 mM (stimulated) glucose for indicated times. (C) Quantitation of ICA512-TMF from two independent experiments as shown in B.
(D) Western blots for ICA512 (top) and  -tubulin (bottom) on 30  g of protein from rat islets that were incubated in resting or stimulating buffers as in A, with or
without 60  M calpeptin. White lines indicate that intervening lanes have beem spliced out. (E) Autoradiographies showing the turnover of newly synthesized
ICA512-TMF (top left) and synaptophysin (syn.; top right) as determined by pulse-chase and immunoprecipitation from [
35S]methionine-labeled INS-1 cells kept
at rest or stimulated for the indicated times. Middle and bottom panels show the total amount of ICA512-TMF (left middle), synaptophysin (right middle), and IgG
heavy chain (bottom panels) in each immunoprecipitate as visualized by Western blotting. (F) Levels of  -calpain and  -actin mRNAs by semiquantitative RT-PCR
in INS-1 cells transfected with scrambled or anti– -calpain siRNA oligos 1. (G) Western blots for  -calpain (top), ICA512 (middle), and  -tubulin (bottom) on 40
 g of protein from stimulated INS-1 cells transfected with scrambled or anti– -calpain siRNA oligos 1. (H) Quantitation of  -calpain and ICA512-TMF from three
independent experiments as shown in G. (I) Western blots for firefly luciferase (top),  -calpain (middle top), ICA512-TMF (middle bottom), and  -tubulin (bottom)
on 30  g of protein in INS-1 cells transfected with firefly luciferase cDNA and untreated or treated with siRNA oligos for firefly luciferase. White lines indicate
that intervening lanes have beem spliced out. (J) Firefly luciferase activity and protein levels of firefly luciferase,  -calpain, and ICA512-TMF from three
independent experiments as shown in I. (K) Western blots for ICA512 (top),  -calpain-V5 (middle), and  -tubulin (bottom) on 40  g of protein from INS-1 cells
transfected with the indicated amount of cDNA for  -calpain-V5 and stimulated as in A. (L) Quantitation of ICA512-TMF from three independent experiments as
shown in K. In B, D, H, J, and L, protein signals were normalized for  -tubulin and expressed as a percentage of their respective values in cells at rest (B and D),
transfected with scrambled siRNA oligos (H) or firefly luciferase cDNA (J), or electroporated (L). Error bars in C, H, J, and L show mean   SD. 
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on ICA512 can be dissociated by stimulating INS-1 cells either
with high glucose or high K
 
 
 
 (Ort et al., 2001). High glucose
alone prompts pro-ICA512 biosynthesis, but only a modest
release of insulin and decrease of ICA512-TMF. In contrast,
high K
 
 
 
 induces a strong insulin secretion and decrease of
ICA512-TMF, but it does not enhance pro-ICA512 biosynthesis.
The reduction of ICA512-TMF depends on the potency of a
stimulus in inducing SG exocytosis. Stimulation with high glu-
cose alone for 30, 60, and 120 min elicits indeed a progressive re-
duction of ICA512-TMF in freshly isolated rat pancreatic islets
(Fig. 1, B and C), which, unlike INS-1 cells, retain a virtually in-
tact secretory responsiveness to glucose. Pro-ICA512 induction
by glucose is less apparent in islets (Fig. 1 D) than in INS-1 cells
because they convert faster pro-ICA512 into ICA512-TMF. This
induction, indeed, is readily detected upon stimulation of islets at
19
 
 
 
C, which blocks protein export from the trans-Golgi network
and thereby pro-ICA512 conversion into ICA512-TMF (Knoch
et al., 2004). Pulse-chase [
 
35
 
S]methionine labelings in INS-1 cells
show that newly synthesized ICA512-TMF has a faster turnover
compared with synaptophysin, an intrinsic membrane protein of
synaptic vesicle/synaptic-like microvesicles, which is known to
participate in multiple rounds of exo-endocytosis (Johnston et al.,
1989; Fig. 1 E). Notably, newly synthesized ICA512-TMF is vir-
tually not detectable in INS-1 cells kept at rest for 2 h after 1 h la-
beling in medium with low glucose (5.5 mM), whereas it is
readily apparent in cells only exposed for 30 min to high glucose
(25 m), which is consistent with the notion that glucose rapidly
up-regulates ICA512 biosynthesis (Knoch et al., 2004).
Exocytosis of SGs leads to the insertion of ICA512-TMF
in the plasma membrane (Solimena et al., 1996) and correlates
with the decrease of ICA512-TMF because of the Ca
 
2
 
 
 
-depen-
dent cleavage of its cytoplasmic domain by calpain (Ort et al.,
2001). This cleavage is indeed prevented in a dose-dependent
manner by calpeptin (Fig. 1 A, lanes 3–5), which inhibits
calpains (Tsujinaka et al., 1988), but not by inhibiting 
 
 
 
-secre-
tase with L-685,458 (Shearman et al., 2000; Fig. 1 A, lanes
6–7) or lysosomal and proteasome activities (Ort et al., 2001).
ICA512-TMF is also decreased in a calpeptin-sensitive fashion
in stimulated islets (Fig. 1 D).
 
ICA512-TMF is cleaved by 
 
 
 
-calpain
 
Among the 14 known calpains, only 
 
 
 
-calpain is activated
by micromolar concentrations of intracellular Ca
 
2
 
 
 
 (Glading
et al., 2002), i.e., within levels elicited by segretagogues to
trigger SG exocytosis. INS-1 cells express 
 
 
 
-calpain, and
calpain activity is enhanced by stimulation of insulin secre-
tion (Ort et al., 2001). In vitro 
 
 
 
-calpain cleaves recombinant
ICA512 cytoplasmic domain between residues 658–659 (Ort
et al., 2001). This site follows a PEST motif (residues 643–
651)—a common proteolytic mark among calpain substrates
(Tompa et al., 2004). Both calpeptin and MG-132, another in-
hibitor of cysteine proteases, prevent this cleavage in vitro
(Fig. S1 A, available at http://www.jcb.org/cgi/content/full/
jcb.200408172/DC1). To establish whether or not 
 
 
 
-calpain
is responsible for cleaving ICA512-TMF in stimulated cells,
its cytoplasmic mRNA (Fig. 1 F) and protein levels (Fig. 1, G
and H) in INS-1 cells were knocked down using three distinct
double-stranded short-interfering RNA (siRNA) oligonucle-
otides, either individually (Fig. 1, G and H) or in combination
(Fig. S1 B). Decrease of 
 
 
 
-calpain inhibits the stimulus-
dependent degradation of ICA512-TMF, whereas knock-
down of transiently transfected firefly luciferase, as verified
by immunoblot and enzymatic assay (Fig. 1, I and J), does
not affect 
 
 
 
-calpain or ICA512-TMF expression. Conversely,
overexpression of 
 
 
 
-calpain increases ICA512-TMF proteol-
ysis only upon stimulation (Fig. 1, K and L; and Fig. S1 C).
These data prove that 
 
 
 
-calpain cleaves ICA512-TMF in
stimulated cells.
Figure 2.  -Calpain is enriched at the plasma membrane. (A) Confocal micros-
copy of INS-1 cells double immunostained with anti– -calpain (pseudogreen)
and anti-ICA512ecto (pseudored) antibodies. Bar, 10  m. (B) Western blots
with anti– -calpain, anti-ICA512, anti-CPE, and anti-Glut2 antibodies on INS-1
cell fractions separated on a continuous sucrose density gradient. The sucrose
molarity of each fraction is indicated on the top. (C) Protein distribution in the
fractions shown in B. The highest signal for each protein was equaled to 100%. 
JCB • VOLUME 167 • NUMBER 6 • 2004 1066
 
ICA512-TMF is cleaved at the plasma 
membrane
 
 
 
-Calpain is recruited to the plasma membrane and activated by
Ca
 
2
 
 
 
 and phospholipids, which are both implicated in neurose-
cretion (Martin, 1998; Wenk and De Camilli, 2004). In INS-1
cells, 
 
 
 
-calpain is mostly restricted to the cortical region (Fig. 2
A, left), where SGs are also enriched, as shown by staining for
ICA512 (Fig. 2 A, middle). After subcellular fractionation,
most 
 
 
 
-calpain is recovered in fractions containing the plasma
membrane marker Glut-2 (Fig. 2, B and C), although a minor
pool is found in the same fractions with ICA512-TMF and car-
boxypeptidase E (CPE), another marker of SGs.
To directly address whether ICA512-TMF cleavage pre-
cedes or follows SG exocytosis, INS-1 cells were transiently
transfected with the light chain of clostridium tetanus toxin,
which blocks the last step in SG fusion with the plasma mem-
brane by cleaving synaptobrevin 2/VAMP2 (Schiavo et al.,
1992; Niemann et al., 1994; Regazzi et al., 1995). The active,
but not the inactive, tetanus toxin light chain, similarly inhibits
ICA512-TMF cleavage (Fig. 3 A) and insulin secretion (Fig. 3 C),
thereby indicating that SG exocytosis and ICA512-TMF inser-
tion in the plasma membrane are necessary in order for the lat-
ter to become susceptible to cleavage.
To test if the cleavage of ICA512-TMF follows its internal-
ization, INS-1 cells were transiently transfected with GFP-tagged
dominant-negative mutant of dynamin 1 (K44A) or dynamin 2
(K44A), which block clathrin-mediated endocytosis (van der
Bliek et al., 1993; Holroyd et al., 2002). Expression of dynamin
1-GFP or dynamin 1 (K44A)-GFP does not alter ICA512-TMF
levels in resting INS-1 cells (Fig. 3 D). In stimulated cells, in-
Figure 3. ICA512 is cleaved by  -calpain at the plasma membrane. (A) Western blottings with anti-ICA512 (top) or GFP (bottom) antibodies on 40  g of
protein from INS-1 cells cotransfected with active (Ttx) or inactive (Ttx-mut.) tetanus toxin light chain and GFP. Cells were incubated in resting or stimulating
buffer for 105 min after 1 h at rest. (B) Quantitation of ICA512-TMF from three independent experiments as shown in A. (C) Stimulation index of insulin
secretion from INS-1 cells that were either nontransfected or transfected with Ttx or Ttx-mut. (D) Western blotting with anti-ICA512 (top) and anti-GFP (bottom)
antibodies on 30  g of protein from INS-1 cells, which were either nontransfected (control) or transiently transfected with dynamin 1-GFP or dynamin 1
(K44A)-GFP and kept in resting buffer for 1 h. White lines indicate that intervening lanes have been spliced out. (E and H) Western blotting with anti-
ICA512 (top) and anti-GFP (bottom) antibodies on 20  g of protein from INS-1 cells, which were either nontransfected (control) or transiently transfected
dynamin 1-GFP or dynamin 1 (K44A)-GFP (E) and with dynamin 2-GFP or dynamin 1 (K44A)-GFP (H). Cells were stimulated for 105 min in the absence
or presence of calpeptin at the indicated concentration. As the expression of dynamin 2 constructs differed, loading of comparable protein amount was
verified by immunoblot for  -tubulin. (F and I) Quantitation of ICA512-TMF from four independent experiments as shown in E and H, respectively. Error
bars in B, C, F, and I show mean   SD. (G) Fluorescence microscopy on INS-1 cells transiently transfected with dynamin 1 (K44A)-GFP (top) or dynamin
1-GFP (bottom) and incubated with Alexa
568-transferrin (Tfn-Alexa568). Bars, 10  m. 
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stead, dynamin 1-GFP increases the stability of ICA512-TMF
(Fig. 3 E), whereas dynamin 1 (K44A)-GFP decreases it, and this
reduction is inhibited by calpeptin in a dose-dependent fashion
(Fig. 3 E). Similar results are observed upon expression of wild-
type or dominant-negative dynamin 2-GFP (Fig. 3, H and I). Up-
take experiments show the internalization of Alexa
 
568
 
-labeled
transferrin in INS-1 cells either nontransfected or transfected
with dynamin 1-GFP or dynamin 2-GFP (Fig. 3 G and Fig. S2,
available at http://www.jcb.org/cgi/content/full/jcb.200408172/
DC1), but not in cells expressing dynamin 1- or dynamin 2
(K44A)-GFP (Fig. 3 G and Fig. S2). Together, these results dem-
onstrate that ICA512-TMF is cleaved at the plasma membrane,
where 
 
 
 
-calpain is enriched (Fig. 2 B) and activated by Ca
 
2
 
 
 
,
whereas endocytosis spares ICA512-TMF from cleavage.
 
ICA512-GFP is correctly sorted and 
processed
 
Recognition by the anti-ICA512 monoclonal antibody of a jux-
tamembrane epitope just upstream of the calpain cleavage site
(Ort et al., 2001) precluded its use for investigating the fate of
the ICA512-cleaved cytosolic fragment (ICA512-CCF). We
overcame this limit by fusing GFP at the COOH terminus of
ICA512. Immunoblots with anti-GFP or anti-ICA512 antibod-
ies on extracts from stable ICA512-GFP INS-1 cells show
pro-ICA512-GFP and ICA512-TMF-GFP having the expected
sizes of 135 and 90 kD, respectively (Fig. 4, A and B). By con-
focal microscopy it appears that most ICA512-GFP colocalizes
with insulin (Fig. 4 C). Specific labeling of granules with GFP
antibody is also found by immunogold electron microscopy on
cryosections (Fig. 4 D). In ICA512-GFP INS-1 cells, 19/87
granules were labeled, compared with 0/102 in nontransfected
INS-1 cells (P 
 
  
 
0.001). Enrichment of ICA512-GFP on SGs
has also been confirmed by subcellular fractionation on sucrose
density gradients (Fig. 4 E). Moreover, limited knockdown of
 
 
 
-calpain is sufficient to decrease ICA512-TMF-GFP cleavage
(Fig. 4 F and Fig. S1 D). Thus, the GFP tag does neither pre-
vent the conversion of pro-ICA512 into ICA512-TMF nor the
targeting of the latter to SGs and its cleavage by 
 
 
 
-calpain.
Figure 4. ICA512-GFP is correctly processed and targeted to SGs. (A and B) Western blottings
with anti-GFP (A) or anti-ICA512 (B) antibodies on 40  g of protein from INS-1 cells nontrans-
fected (control) or stably transfected with ICA512-GFP. (C) Confocal microscopy on INS-1
ICA512-GFP cells immunostained for insulin (pseudored). Bar, 10  m. (D) Immunoelectron
microscopy on resting INS-1 ICA512-GFP cells double labeled with anti-insulin (6 nm of gold)
and anti-GFP (12 nm of gold; arrowheads) antibodies. PM, plasma membrane. Bar, 200 nm.
(E) Western blottings with anti-GFP, anti-ICA512, anti-CPE, and anti-Glut2 antibodies on
fractions of INS-1 ICA512-GFP cells separated on a continuous sucrose density gradient.
The sucrose molarity of each fraction is indicated on the top. (F) Western blots for  -calpain
(top), ICA512 (middle), and  -tubulin (bottom) on 40  g of protein from INS-1 cells trans-
fected with scrambled or anti– -calpain siRNA oligos 1 or 3. 
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ICA512-CCF is targeted to the nucleus
 
The stimulation-dependent proteolysis of ICA512-TMF-GFP is
calpeptin-sensitive (Fig. 5 A, top panel). Strikingly, a GFP-react-
ing protein, whose size of 55 kD matches the one expected for
ICA512-CCF-GFP, is enriched in nuclear, but not in cytosolic,
fractions of stimulated ICA512-GFP INS-1 cells, also in a
calpeptin-sensitive fashion (Fig. 5 A, top panel, lanes 4–6). Pre-
dictably, this 55-kD protein is not recognized by the anti-ICA512
monoclonal antibody (Fig. 5 A, middle panel). ICA512-CCF-
GFP is already present in the nuclei of cells at rest for 165 min.
Figure 5. ICA512-CCF is translocated to the nucleus upon stimulation. (A) Western blots with anti-GFP (top), anti-ICA512 (middle), and  -tubulin (bottom)
on 50  g of cytoplasmic and 25  g of nuclear protein from INS-1 ICA512-GFP cells. Cells were incubated with resting or stimulating buffer for 105 min
after 1 h at rest and with or without 60  M calpeptin. (B) 0.5- m optical Z-sections of INS-1 ICA512-GFP cells kept at rest (R; top) or stimulated (S; bottom)
as in A and immunolabeled with anti-insulin antibody (pseudored). ICA512-GFP is shown as pseudogreen, whereas nuclei were counterstained with DAPI
(pseudoblue). Insets in the right panels show high magnifications of the marked areas. (C) Western blots with anti-GFP on 40  g of cytoplasmic and 20
 g of nuclear protein from INS-1 ICA512-GFP cells incubated as in A for the indicated times. (D) Quantitation of ICA512-TMF-GFP and ICA512-CCF-GFP
in cytoplasmic (black line) and nuclear (red line) extracts at the indicated time points 1–6. Values are from four independent experiments as shown in C.
For graphic representation, the amounts of ICA512-TMF-GFP and ICA512-CCF-GFP after 105 min in resting buffer (time point 2) were equaled to 100%
and 50%, respectively. Error bars show mean   SD. (E) 0.5- m optical Z-sections of INS-1 cells transiently transfected with ICA512-HA, kept at rest (R; top)
or stimulated (S; bottom) as in A, and immunolabeled with rabbit anti-HA (pseudogreen) and mouse anti-insulin (pseudored) antibodies. Nuclei were
counterstained with DAPI (pseudoblue). Insets in the right panels show high magnifications of the marked areas. Bars, 10  m.ICA512 NUCLEAR TRANSLOCATION AND SIGNALING • TRAJKOVSKI ET AL. 1069
Conceivably, this time is insufficient to clear the nuclei from
ICA512-CCF-GFP that is constantly generated in cells cultured
with 11 mM glucose, which stimulates sub-maximal exocytosis.
Confocal microscopy shows an accumulation of GFP-pos-
itive dots in the nuclei of stimulated INS-1 ICA512-GFP cells
versus those of resting cells (Fig. 5 B, insets; and Videos 1 and 2,
available at http://www.jcb.org/cgi/content/full/jcb.200408172/
DC1). Concomitantly, the cytosolic colocalization of ICA512-
GFP and insulin is decreased, reflecting the reduced insulin con-
tent and the internalization of ICA512-TMF-GFP in stimulated
cells. The accumulation of ICA512-CCF-GFP in the nuclei
of stimulated cells correlates with the increased reduction of
ICA512-TMF-GFP over time (Fig. 5, C and D) and is already
detectable after 20 min stimulation (Fig. 5 D).
ICA512-CCF does not contain a canonic nuclear import
signal. To rule out the possibility that its nuclear translocation
results from its tagging with GFP, we analyzed the distribution
of GFP alone as well as that of an ICA512 construct carrying
as a distinct tag a triple HA epitope at its COOH terminus
(ICA512-HA3). Nuclear extracts of stimulated cells contain
less GFP than those of resting cells (Fig. 5 C and Fig. S3, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200408172/DC1).
ICA512-HA3, which is correctly processed (Fig. S4 A, available
at http://www.jcb.org/cgi/content/full/jcb.200408172/DC1), is
also enriched in the nuclei of stimulated cells, as shown by im-
munoblotting (Fig. S4 B) and confocal microscopy with an
anti-HA antibody (Fig. 5 E and Videos 3 and 4). Together,
these data indicate that SG exocytosis and ICA512-TMF cleav-
age at the plasma membrane are coupled to the generation of
ICA512-CCF, which is targeted to the nucleus.
ICA512-CCF binds protein inhibitor of 
activated STAT (PIAS)-y in the nucleus
Screening by 2-hybrid assays in yeast showed that the cytoplas-
mic domain of ICA512 binds PIASy (unpublished data). PIASs
were originally identified as PIAS (Liu et al., 1998) and have
been more recently shown to have E3-sumoylating activity to-
ward numerous transcription factors, including p53 and signal
transducers and activators of transcription (STATs; Johnson and
Gupta, 2001; Takahashi et al., 2001; Melchior and Hengst, 2002;
Schmidt and Muller, 2002). The binding of ICA512 cytoplasmic
domain to PIAS proteins, including PIASy and PIAS1, was con-
firmed by pull-down assays (Fig. 6 A). Specifically, 
35S-labeled
human ICA512 cytoplasmic domain (residues 601–979) gener-
ated by in vitro transcription and translation is recovered on glu-
tathione-sepharose beads coupled with PIASy-GST or PIAS1-
Figure 6. ICA512-CCF binds PIASy in the nucleus. (A) SDS-PAGE and autoradiography of in vitro transcribed and translated [
35S]methionine-labeled
ICA512(601–979) pulled down with glutathione sepharose beads coupled to 0.5  g PIASy-GST, PIAS1-GST, or GST alone. Lane 1 shows the starting
labeled material for the pull-down assay. White lines indicate that intervening lanes have been spliced out. (B) SDS-PAGE and autoradiography of in vitro
transcribed and translated [
35S]methionine-labeled PIASy pulled down with glutathione sepharose beads coupled to 0.5  g GST-ICA512(601–979), GST-
p53, or GST alone. First lane shows the starting labeled material for the pull-down assay. (C) FRET between ICA512-CFP (pseudocyan) and PIAS -YFP
(pseudogreen) in transiently cotransfected INS-1 cells incubated in resting or stimulating buffer for 105 min after 1 h at rest. The right panels show the signal
for ICA512-CFP following the photobleaching of PIASy-YFP in the circled nuclei (arrows). (D) Quantitation of FRET to CFP in INS-1 cells transiently cotransfected
with the indicated constructs: ICA512-CFP   PIASy-YFP; ICA512-CFP   lsm4-YFP; lsm4-CFP   PIASy-YFP. Values are from two independent experiments
as shown in C. (D) Error bars show mean   SD.JCB • VOLUME 167 • NUMBER 6 • 2004 1070
GST, but not with GST alone (Fig. 6 A). Likewise, 
35S-labeled
PIASy interacts specifically with GST-ICA512(601–979) and
GST-p53 (Fig. 6 B). Fluorescence resonance energy transfer
(FRET) analyses in INS-1 cells transiently cotransfected with
ICA512-CFP and PIASy-YFP show that the two proteins interact
in the nucleus (Fig. 6 C). Specifically, the ICA512-CFP nuclear
signal after photobleaching (Fig. 6 C, circled areas) is increased
approximately fivefold upon stimulation (Fig. 6 D). In parallel
experiments, no interaction is detected between ICA512-CCF-
CFP and the nuclear protein lsm4-YFP (Fig. 6 D and Fig. S5,
available at http://www.jcb.org/cgi/content/full/jcb.200408172/
DC1) and between lsm4-CFP and PIASy-YFP (Fig. 6 D) in ei-
ther resting or stimulating conditions, thereby confirming the
specific interaction of ICA512-CCF with PIASy in the nucleus.
ICA512-CCF enhances insulin gene 
expression
To test whether or not ICA512-CCF is a retrograde signal that
couples regulated secretion and gene expression, possibly
through PIASy, INS-1 cells were transiently transfected
with the ICA512 cytoplasmic fragment generated in vitro by
 -calpain (Ort et al., 2001; Fig. S1), which was tagged at its
COOH terminus with GFP (ICA512(659–979)-GFP). Notably,
ICA512(659–979) includes the catalytically inactive PTP do-
main. Confocal microscopy (Fig. 7 A) and Western blotting
(Fig. 7 B) show that the nuclei of resting and stimulated cells
contain comparable amounts of ICA512(659–979). Strikingly,
insulin mRNA levels are increased by 32 and 93% in resting
INS-1 cells expressing ICA512-GFP or ICA512(659–979)-
GFP, respectively, but are not changed by the expression of
GFP alone (Fig. 7 C). The higher levels of insulin mRNA in
ICA512-GFP cells can be attributed to an increased generation
of ICA512-CCF-GFP, as insulin mRNA is enhanced in parallel
with the expression of ICA512(659–979)-GFP (Fig. 7 D). Ac-
cordingly, knockdown of  -calpain decreases insulin mRNA
(Fig. 7 E). Likewise, calpeptin has an adverse effect on insulin
mRNA in stimulated cells (Fig. 7 F). In these experiments,
cells were either kept at rest or stimulated for up to 6 h, with or
Figure 7. ICA512-CCF promotes insulin gene expression. (A) Confocal microscopy on INS-1 cells transiently transfected with ICA512 (659–979)-GFP and
counterstained with DAPI. Bar, 10  m. (B) Western blot with goat anti-GFP (top) and anti– -tubulin (bottom) antibodies on 6  g of nuclear protein from INS-1
cells transiently transfected with ICA512(659–979)-GFP and incubated with resting or stimulating buffer for 105 min after 1 h at rest. (C) Insulin mRNA levels
quantified by real-time PCR in INS-1 cells that were either electroporated only or transfected with 4  g of vector encoding GFP, ICA512-GFP, or
ICA512(659–979)-GFP and kept at rest for 1 h. The results are from three independent experiments, each in triplicate. (D) Insulin mRNA levels quantified by
real-time PCR in INS-1 cells which were either electroporated only or transfected with 0.5–4  g ICA512(659–979)-GFP and collected after 4 d in culture
with 11 mM glucose. The results are from four independent experiments, each in triplicate. In C and D, the levels of insulin mRNA in electroporated cells
were equaled to 100%. In D, ICA512(659–979)-GFP and  -tubulin levels were assessed by Western blotting with goat anti-GFP (middle) and anti- -tubulin
(bottom) antibodies. (E) Insulin mRNA levels quantified by real-time PCR in INS-1 cells transfected either with scrambled or anti– -calpain siRNA oligos 1   2.
The results are from three independent experiments, each in triplicate. The level of insulin mRNA in cells transfected with the scrambled oligos was equaled
to 100%. Error bars (C, D, and E) show mean   SD. (F) Insulin mRNA levels quantified by real-time PCR in INS-1 cells that were at rest (2.8 mM glucose and
5 mM KCl) for 1 h, then in resting or stimulating buffer, with or without 40  M calpeptin, for up to 6 h (pulse), and finally in resting buffer for up to 24 h
(chase). Total RNA was collected at 0-, 2-, and 6-h time points of the pulse and then at 2-, 6-, 12-, and 24-h time points of the chase. The results are from
three independent experiments, each in triplicate. The level of insulin mRNA in resting INS-1 cells was equaled to 100%. Error bars show mean   SD.ICA512 NUCLEAR TRANSLOCATION AND SIGNALING • TRAJKOVSKI ET AL. 1071
without 40  M calpeptin, and then returned to resting medium
for up to 24 h. Maximal levels of insulin mRNAs are present
2 h after the 6-h stimulation period. However, in calpeptin-
treated cells, insulin mRNA is reduced by  40% at this time
point as well as at any later time point compared with cells
stimulated in the absence of calpeptin. The magnitude of this
decrease correlates well with the degree of calpeptin-mediated
inhibition of ICA512-TMF cleavage (Fig. 1 B). 
Discussion
In this work, we have identified a novel retrograde pathway
that directly links regulated exocytosis and gene expression
through the cleavage of a receptor tyrosine phosphatase-like
protein associated with insulin SGs. Specifically, we show that
stimulation promotes the cleavage of ICA512-TMF by  -cal-
pain. The resulting ICA512-CCF translocates to the nucleus,
where it binds PIASy and promotes insulin gene expression.
Our data demonstrate that ICA512-TMF is cleaved while
resident in the plasma membrane, following SGs exocytosis
and before its internalization. Multiple factors contribute to the
temporal and spatial restriction of this process. First, activation
of  -calpain requires concentrations of intracellular Ca
2  that
are only transiently induced by stimulation of exocytosis and
only in close proximity of the plasma membrane. Second,
ICA512-TMF cytoplasmic tail binds  2-syntrophin on SGs in
the cell cortex (Ort et al., 2000).  2-Syntrophin, in turn, is as-
sociated with the F-actin binding protein utrophin. Therefore,
the ICA512-TMF/ 2-syntrophin/utrophin complex may anchor
SGs with the cortical actin cytoskeleton (Ort et al., 2001; Soli-
mena and Gerdes, 2003). Notably, the PDZ domain of  2-syn-
trophin binds ICA512-TMF between the PEST motif and the
PTP domain (Ort et al., 2000) and this binding prevents the in
vitro processing of ICA512 cytoplasmic domain by  -calpain
(Ort et al., 2001), conceivably by masking the cleavage site.
Furthermore, stimulation of exocytosis appears to promote
a Ca
2 -dependent dephosphorylation of  2-syntrophin and
thereby its dissociation from ICA512 (Ort et al., 2001; unpub-
lished data). Together, these data point to Ca
2  as a signal that
elicits the fusion of SGs, the insertion of ICA512-TMF in the
plasma membrane, its dissociation from  2-syntrophin, and its
cleavage by activated  -calpain, which is either bound to the
plasma membrane or already found on SG membranes in prox-
imity of ICA512-TMF. Binding of ligands to the ICA512 ex-
tracellular domain upon its exposure at the cell surface might
further regulate the intracellular cleavage of ICA512-TMF.
Glucose is the most important factor regulating the ex-
pression of insulin, ICA512, and most other components of
 -cell SGs. Such regulation is a complex process, which depends
on transcriptional and posttranscriptional mechanisms as well
as on glucose metabolism and SG exocytosis. Posttranscrip-
tional mechanisms account for the increased biosynthesis of in-
sulin and most other SG proteins within 2 h after stimulation
(Itoh and Okamoto, 1980; Welsh et al., 1986). Specifically,
glucose induces the rapid nucleocytoplasmic translocation of
polypyrimidine-tract binding protein, which binds mRNAs of
SG components (Knoch et al., 2004), including insulin (Tillmar
et al., 2002), thereby increasing their stability and translation.
Transcriptional mechanisms are critical for glucose regulation
of insulin gene expression over a longer period of time. Major
transcription factors that enhance insulin expression include
Beta2/NeuroD, PDX-1, and RIPE3b1-Act/C1 (Melloul et al.,
2002). Although the precise mechanism by which ICA512-
CCF increases insulin gene expression remains to be defined,
both its nuclear localization and its interaction with the SUMO-
ligase PIASy suggest that it modulates transcription. Interest-
ingly, sumoylation of PDX-1 enhances its stability, nuclear lo-
calization, and induction of insulin gene transcription (Kishi et
al., 2003). In contrast, binding of RIPE3b1-Act/C1 to the C1
element in the insulin promoter is regulated by tyrosine phos-
phorylation (Zhao et al., 2000; Matsuoka et al., 2001). Thus, it
would be interesting to test whether ICA512-CCF enhances in-
sulin transcription by promoting the sumoylation of PDX-1 by
PIAS proteins and/or by preventing the dephosphorylation of
RIPE3b1-Act/C1 through its inactive PTP domain. An addi-
tional effector of ICA512-CCF could be STAT-5, which stimu-
lates insulin gene expression and  -cell proliferation upon
stimulation with growth hormone and prolactin (Nielsen et al.,
2001). Interestingly, STAT-5 is activated by tyrosine phos-
phorylation (Herrington et al., 2000), whereas it is inhibited by
PIAS3 (Rycyzyn and Clevenger, 2002). Moreover, induction
of insulin gene expression by growth hormone depends on
Ca
2  uptake, as it its prevented by verapamil, which blocks
voltage-gated Ca
2  channels (Billestrup et al., 1995). Besides
verapamil (German et al., 1990), other agents that block volt-
age-gated Ca
2  channels, such as D600 (Efrat et al., 1990) and
nimodipine (Leibiger et al., 1998), were found to inhibit glu-
cose-stimulated insulin gene expression in islets and insu-
linoma cells. However, these findings are still debated in view
of seemingly discordant results by others (Goodison et al.,
1992; de Vargas et al., 1997; Kennedy et al., 1999).
The effect of Ca
2  entry on insulin transcription has been
partly attributed to its induction of insulin secretion (Leibiger
et al., 1998). According to this interpretation, insulin acts as an
autocrine signal that promotes its own gene expression through
the activation of pathways downstream of insulin receptors in
 -cells. However, more recent analyses have suggested that in-
sulin receptors control islet development and the secretion
(Kulkarni et al., 1999; Otani et al., 2004) but not the expression
(Kennedy et al., 1999; Wicksteed et al., 2003) of insulin. Our
findings point to the activation of  -calpain and the generation
of ICA512-CCF as a means by which Ca
2  can support glucose
in inducing insulin gene expression.
Similar to ICA512, proteolytic cleavage of receptor pro-
teins such as Notch and the Alzheimer’s disease amyloid pre-
cursor protein (APP) generate intracellular fragments that are
targeted to the nucleus and regulate gene expression (Fortini,
2002). The analogy of ICA512 with APP extends further, as
processing of the latter is also modulated by calpain (Chen et
al., 2004) and the cytoplasmic tail of both proteins binds PDZ-
domain–containing proteins (Borg et al., 1998; Tomita et al.,
1999; Ort et al., 2000). As discussed earlier in this section,
binding of  2-syntrophin could prevent ICA512-TMF cleav-
age and thereby its effect on gene expression. Likewise, the cy-JCB • VOLUME 167 • NUMBER 6 • 2004 1072
tosolic tail of APP binds the phosphotyrosine binding domain
of Mints/X11s (Borg et al., 1998; Tomita et al., 1999), whose
COOH-terminal PDZ domains, in turn, regulate the processing
of APP and its transcriptional activity (Biederer et al., 2002).
However, the case of ICA512 is unique as its cleavage is di-
rectly coupled in time and space to the exocytosis of SGs.
Moreover, ICA512 is processed by  -calpain without an in-
volvement of  -secretase, as it is the case for Notch and APP.
In conclusion, we propose a mechanistic model whereby
cleavage of ICA512 upon SG exocytosis and translocation of
its cytoplasmic tail to the nucleus allow  -cells to monitor their
secretory activity in response to stimulation and to adjust their
expression of insulin, and conceivably that of other genes, ac-
cordingly. As ICA512 is associated with SGs in virtually all
neuroendocrine cells, this mechanism could be of general rele-
vance for peptide hormone and neuropeptide secretion.
Materials and methods
Islet isolation and cell culture
Pancreatic islets from female Wistar rats were isolated and cultured (400/
60 mm culture dish) as described previously (Gotoh et al., 1985). INS-1
cells were grown as described previously (Asfari et al., 1992).
cDNA cloning and transfection
Human ICA512 and ICA512(659–979) cDNAs were subcloned into pEGFP-
N1 or pECFP-N1 (CLONTECH Laboratories, Inc.) as EcoRI–AgeI or AgeI–
BglII inserts in frame with GFP or CFP, respectively. ICA512 was tagged at its
COOH terminus with 3-HA epitopes by subcloning its cDNA as a KpnI–XbaI
insert into the MoHa3 vector (a gift from M. Suchanek, Max Planck Institute of
Molecular Cell Biology and Genetics [MPI-CBG], Dresden, Germany). Plas-
mids encoding proteolytically active and inactive tetanus toxin light chain
were a gift from T. Binz (Medizinische Hochschule Hannover, Hannover, Ger-
many; McMahon et al., 1993). The cDNAs of rat dynamin 1 and 2 and their
corresponding dominant-negative (K44A) alleles fused to GFP were a gift
from K. Simons (MPI-CBG, Dresden, Germany). Murine PIASy cDNA (a gift
from R. Grosschedl, University of Munich, Munich, Germany) was inserted as
EcoRI–BglII insert into pEYFP-N2 (CLONTECH Laboratories, Inc.). The cDNAs
for lsm4-CFP and lsm4-YFP were a gift from K. Neugebauer (MPI-CBG, Dres-
den, Germany). The GeneStorm clone for human  -calpain-V5 was pur-
chased (Invitrogen). 4   10
6 INS-1 cells were electroporated with an Amaxa
nucleoporator (Amaxa Biosystems) using the nucleofector kit V and the pro-
gram T-20 (transfection efficiency  50%). Electroporated cells were aliquoted
in two 35-mm wells and grown for 4 d before harvesting. INS-1 cells stably
expressing ICA512-GFP were selected with 600  g/ml neomycin and
cloned by limiting dilution. Two clones expressing ICA512-GFP, as assessed
by Western blotting and confocal microscopy, were selected for FACS using
GFP fluorescence and further characterized.
Cell extraction and Western blotting
Unless otherwise stated, INS-1 cells and rat pancreatic islets (350–450)
were preincubated for 1 h in resting buffer (0 mM glucose and 5 mM KCl)
and then for various times in fresh resting or stimulating (25 mM glucose
and 55 mM KCl or 25 mM glucose alone) buffer as described previously
(Ort et al., 2001; Knoch et al., 2004). The protease inhibitors calpeptin,
MG-132, and L-685,458 (Calbiochem) were added in the last 15 min of
the preincubation, and then for the entire following period before cells
were harvested. Cells were washed with ice cold PBS and extracted in ly-
sis buffer (10 mM Tris-HCl, pH 8.0, 140 mM NaCl, 1% Triton X-100,
1 mM EDTA, 1 mM PMSF, and 1% protease inhibitor cocktail [Sigma-
Aldrich]) at 4 C. Cytosolic and nuclear extracts were prepared with the
NE-PER Nuclear and Cytoplasmic Extraction Reagents (Pierce Chemical
Co.), according to the manufacturer’s protocol. Protein concentration was
assessed with the Protein Assay Reagent (Bio-Rad Laboratories). Proteins
were separated by 8–10% SDS-PAGE, transferred on nitrocellulose filters,
and detected with the following antibodies: mouse monoclonals anti-
ICA512 (Hermel et al., 1999), anti– -calpain (Chemicon), anti– -tubulin
and anti-HA (Sigma-Aldrich), and anti-GFP (CLONTECH Laboratories,
Inc.); rabbit polyclonals anti-Glut2 (Alpha Diagnostics International), anti-
CPE (Chemicon), anti-GFP (Molecular Probes), and anti-HA (a gift from C.
Thiele, MPI-CBG, Dresden, Germany); and anti-V5-HRP (Invitrogen). Pro-
tein signals were detected by chemiluminescence with the Supersignal
West Pico Substrate (Pierce Chemical Co.) using a LAS 3000 Bioimaging
System (Fuji) and quantified with the Image Gauge v3.45 software (Fuji).
Pulse-chase labeling and immunoprecipitation
4   10
7 INS-1 cells grown in culture for 4 d were starved for 1 h in methi-
onine-free labeling medium with 5.5 mM glucose (BioConcept), and then
pulsed with 800  Ci [
35S]methionine in the same buffer for 1 h at 19 C to
prevent the exit of newly synthesized secretory proteins, including pro-
ICA512, from the trans-Golgi network. Next, cells were either stimulated
for 30, 60, or 120 min or kept at rest for 120 min at 37 C and extracted
in lysis buffer. 3.6 mg of protein from each lysate was incubated for
90 min with 60  l of 50% slurry protein G–sepharose (Amersham Bio-
sciences) in 900  l for precleaning. After centrifugation, each supernatant
was split in two aliquots, which were incubated overnight either with a rab-
bit affinity-purified antibody directed against the juxtamembrane domain
of ICA512 (Hermel et al., 1999) or with a mouse monoclonal anti-synapto-
physin antibody (Synaptic Systems GmbH). Protein G–sepharose beads
were added the next day for 90 min, centrifuged and washed eight times
with 1 ml of lysis buffer, and finally resuspended and boiled in SDS-sample
buffer. Proteins were separated by 8% SDS-PAGE and transferred on nitro-
cellulose. Autoradiographies of the filters were collected with a phospho-
imager (model BAS 1800 II; Fuji) after 2.5 d of exposure, and processed
with Image Reader V1.8 (Fuji). The same filters were immunoblotted with
mouse monoclonal anti-ICA512 or anti-synaptophysin antibodies.
Time course stimulation
INS-1 cells were incubated for 1 h in resting buffer (2.8 mM glucose and
5 mM KCl) and for 6 h in resting or stimulating buffer, with or without 40
 M calpeptin, and then again in resting buffer for up to 24 h. Total RNA
for real-time PCR was collected at time 0, 2, and 6 h during stimulation
and at 2, 6, 12, and 24 h during the following resting period.
Sucrose density gradient fractionation
INS-1 and INS-1 ICA512-GFP cells were fractionated on continuous su-
crose density gradients from 0.4–2 M as described previously (Ort et al.,
2000). Fractions were separated by SDS-PAGE and analyzed by immuno-
blotting as indicated in Cell extraction and Western blotting.
GST pull-down assays
ICA512(601–979) in pET28a (Ort et al., 2000) and PIASy in pcDNA3.1
(Invitrogen) were transcribed and translated in vitro with the T7/coupled
transcription-translation system (Promega). PIAS1-GST, PIAS -GST, GST-
p53, and GST-ICA512(601–979) were expressed in bacteria as de-
scribed previously (Ort et al., 2000; Sachdev et al., 2001; Schmidt and
Muller, 2002). [
35S]methionine-labeled ICA512(601–979) or PIASy were
incubated overnight at 4 C in GST binding buffer (120 mM NaCl, 50 mM
Tris, pH 8, 0.25% NP-40, 1 mM DTT, and 1 mM PMSF) with GST-fusion
proteins or GST alone coupled to glutathione-sepharose beads (Amersham
Biosciences). Beads were washed five times with binding buffer and
eluted with 10 mM of reduced glutathione. The eluate was subjected to
SDS-PAGE and analyzed by autoradiography.
In vitro  -calpain cleavage of ICA512
3  g of bacterially expressed His-ICA512(601–979) was digested with
 -calpain (Calbiochem), with or without 30  M calpeptin or MG-132, as
described previously (Ort et al., 2001).
Immunocytochemistry
INS-1 cells in resting or stimulated buffers were fixed with 2% PFA, perme-
abilized with 0.2% saponin, and immunostained with mouse monoclo-
nal anti– -calpain and insulin (Sigma-Aldrich) or rabbit polyclonal anti-
ICA512ecto (Solimena et al., 1996) antibodies for 1 h, followed by goat
anti–mouse Alexa
488- or Alexa
568-conjugated IgGs (Molecular Probes).
Nuclei were counterstained with DAPI (Sigma-Aldrich). 0.5- m Z-section
images were acquired with an inverted 405-nm confocal microscope
(model LSM Meta; Carl Zeiss MicroImaging, Inc.).
EM
Cells were fixed with 4% PFA in 60 mM Pipes, 25 mM Hepes, 10 mM
EDTA, and 2 mM MgCl2, pH 6.9, for 1 h at RT and scraped and pelleted
in PBS with 10% gelatin. Pellets were fixed and stored in PBS with 1%
PFA. Ultrathin cryosections were prepared as described previously (Moo-
lenaar et al., 1997) and incubated with mouse anti-insulin (Sigma-Aldrich;ICA512 NUCLEAR TRANSLOCATION AND SIGNALING • TRAJKOVSKI ET AL. 1073
1:1,000) and rabbit anti-GFP (Molecular Probes; 1:500) antibodies fol-
lowed by goat anti–mouse and goat anti–rabbit IgGs conjugated to 6 nm
of gold and 12 nm of gold particles, respectively (Dianova; 1:30). Speci-
ficity of the GFP-labeling on granules was assessed by morphometry in
two independent experiments.
FRET
INS-1 cells transiently cotransfected with ICA512-CFP, PIAS -YFP, lsm4-
YFP, and lsm4-CFP were kept at rest or stimulated for 90 min. FRET in 2%
PFA fixed cells was assessed by measuring the dequenching of CFP during
the photobleaching of YFP performed with the 514-nm laser line at 70%
power and for six cycles of 30 s each. Mean fluorescence of CFP and YFP
were determined by tracing the nuclear perimeter using the “region of in-
terest” software function. Fluorescence intensity of CFP after photobleach-
ing was normalized to 100% at time 0. Six to nine fields for each slide
were photobleached and recorded. Each experiment was independently
performed two times.
Transferrin uptake assay
INS-1 cells transfected with dynamin-GFP constructs were starved for 1 h in
medium without FBS and incubated for 15 min in serum-free medium with
Alexa
568-transferrin (Molecular Probes) and 1 mg/ml BSA on 37 C. Cells
were washed 4  in cold PBS and fixed as indicated in the section Immu-
nocytochemistry. Images were acquired with a CCD camera (CoolSnap-
HQ; Roper Scientific) attached to a microscope (model BX61; Olympus)
and processed with Metamorph 4.65 software (Universal Imaging Corp.).
RNA interference
INS-1 cells (6   10
5/35-mm well) were grown for 2 d before transfection.
21-mer silencing RNA (siRNA) oligonucleotides 1, 2, and 3 for rat
 -calpain were synthesized with the Silencer siRNA Construction Kit
(Ambion) using the following primers: sense 1, 5 -AAGAGAGCGCTCCA-
GAACTCGCCTGTCTC-3 ; antisense 1, 5 -AACGAGTTCTGGAGCGC-
TCTCCCTGTCTC-3 ; sense 2, 5 -AACCTGGATCTGGTCATCTAGCCT-
GTCTC-3 ; antisense 2, 5 -AACTAGATGACCAGATCCAGGCCTGTCTC-
3 ; sense 3, 5 -AAGTTACTGACCTCTCGAAGGCCTGTCTC-3 ; antisense
3, 5 -AACCTTCGAGAGGTCAGTAACCCTGTCTC-3 . Cells were trans-
fected on day 2 and 4 with 1  g of siRNA oligos per well in Optimem me-
dium with Lipofectamine (Invitrogen). On day 6, cells were harvested and
processed for RT-PCR, real-time PCR, or immunoblotting.
Firefly luciferase assay
2 d before transfection of siRNA oligos for firefly luciferase (Knoch et al.,
2004), INS-1 cells were electroporated with pGL3-Basic and phRL vectors
(Promega) for coexpression of firefly and renilla luciferase, respectively.
Firefly luciferase expression and activity were measured 6 d after plating
of the cells.
Insulin RIA
Cells were extracted overnight in 3:1:0.06 volumes of ethanol, H2O, and
37% HCl at  20 C. Insulin content in the cells and in the medium was
measured with the Sensitive Rat Insulin RIA Kit (Linco Research). The stim-
ulation index was calculated as follows: secreted insulin:cell insulin con-
tent   secreted insulin from stimulated cells/secreted insulin:cell insulin
content   secreted insulin from resting cells. The stimulation index from
control cells was equaled to 100%.
RT-PCR
Cytosolic RNA was isolated using RNeasy Mini Kit (QIAGEN) according
to the manufacturer’s protocol. 1  g of RNA was used for the simulta-
neous amplification of rat  -calpain and  -actin cDNAs by RT-PCR using
the Titan One Tube RT-PCR System (Roche Diagnostics) and 0.4  M prim-
ers for each gene. Primers for  -calpain were as follows: sense, 5 -AAC-
GAGTTCTGGAGCGCTCTC-3 ; antisense, 5 -CTTCAGAATGATCTGGTA-
GAGG-3 . The number of cycles had been optimized to be within the
logarithmic phase of the reaction. PCR products were separated on 2%
agarose gels, stained with ethidium bromide, and semiquantitated with
the GeneSnap software (Syngene) following image acquisition with
GeneGnome (Syngene).
Real-time PCR
Total RNA from INS-1 cells was isolated with Trizol (Invitrogen) according
to the manufacturer’s protocol. 1  g of total RNA was used for reverse
transcription with 2  M of specific antisense primers for insulin and
 -actin, as described previously (Steinbrenner et al., 2002). mRNA ex-
pression was measured by quantitative real-time PCR using the Brilliant
SYBR Green QPCR (Stratagene) with an Mx4000 Multiplex Quantitative
Real Time PCR System (Stratagene).
Online supplemental material
Fig. S1 shows that ICA512 is a substrate of µ-calpain cleavage both in
vitro and within cells. Fig. S2 shows that dynamin 2 (K44A)-GFP inhibits
the uptake of transferring in INS-1 cells. Fig. S3 shows that GFP is not en-
riched in the nuclei of stimulated INS-1 cells. Fig. S4 shows that ICA512-
HA3 is correctly processed and targeted to the nucleus of stimulated INS-1
cells. Fig. S5 is of FRET images showing that ICA512-CFP does not inter-
act with the control protein lsm4-YFP in the nucleus of stimulated INS-1
cells. Video 1 is a stack of serial optical confocal Z-sections showing the
low levels of ICA512-GFP in the nuclei of resting INS-1 cells. Video 2 is a
stack of serial optical confocal Z-sections showing the high levels of
ICA512-GFP in the nuclei of stimulated INS-1 cells. Video 3 is a stack of
serial optical confocal Z-sections showing the low levels of ICA512-HA3
in the nuclei of resting INS-1 cells. Video 4 is a stack of serial optical con-
focal Z-sections showing the high levels of ICA512-HA3 in the nuclei of
stimulated INS-1 cells. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200408172/DC1.
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